120 related articles for article (PubMed ID: 20888624)
1. Evaluation of combined oncological and functional outcomes after radical prostatectomy: trifecta rate of achieving continence, potency and cancer control--a literature review.
Xylinas E; Ploussard G; Durand X; de La Taille A; Gillion N; Allory Y; Vordos D; Hoznek A; Abbou CC; Salomon L
Urology; 2010 Nov; 76(5):1194-8. PubMed ID: 20888624
[TBL] [Abstract][Full Text] [Related]
2. Editorial comment. evaluation of combined oncological and functional outcomes after radical prostatectomy: trifecta rate of achieving continence, potency and cancer control--a literature review.
Guillonneau BD
Urology; 2010 Nov; 76(5):1199; author reply 1199-200. PubMed ID: 21056267
[No Abstract] [Full Text] [Related]
3. Editorial comment. Evaluation of combined oncological and functional outcomes after radical prostatectomy: trifecta rate of achieving continence, potency and cancer control--a literature review.
Litwin MS
Urology; 2010 Nov; 76(5):1198; author reply 1198-9. PubMed ID: 21056265
[No Abstract] [Full Text] [Related]
4. Preoperative risk stratification predicts likelihood of concurrent PSA-free survival, continence, and potency (the trifecta analysis) after radical retropubic prostatectomy.
Pierorazio PM; Spencer BA; McCann TR; McKiernan JM; Benson MC
Urology; 2007 Oct; 70(4):717-22. PubMed ID: 17991543
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of combined oncological and functional outcomes after laparoscopic radical prostatectomy: trifecta rate of achieving continence, potency and cancer control at 2 years.
Ploussard G; de la Taille A; Xylinas E; Allory Y; Vordos D; Hoznek A; Abbou CC; Salomon L
BJU Int; 2011 Jan; 107(2):274-9. PubMed ID: 20575978
[TBL] [Abstract][Full Text] [Related]
6. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta").
Bianco FJ; Scardino PT; Eastham JA
Urology; 2005 Nov; 66(5 Suppl):83-94. PubMed ID: 16194712
[TBL] [Abstract][Full Text] [Related]
7. Introducing a new, simple scoring system to evaluate oncological and functional outcome after radical prostatectomy.
Salomon L; Anastasiadis A; Saint F; De La Taille A; Chopin D; Abbou CC
Scand J Urol Nephrol; 2003; 37(5):392-5. PubMed ID: 14594687
[TBL] [Abstract][Full Text] [Related]
8. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
[TBL] [Abstract][Full Text] [Related]
9. Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer.
Carini M; Masieri L; Minervini A; Lapini A; Serni S
Eur Urol; 2008 Mar; 53(3):554-61. PubMed ID: 17683854
[TBL] [Abstract][Full Text] [Related]
10. A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes.
Boorjian SA; Eastham JA; Graefen M; Guillonneau B; Karnes RJ; Moul JW; Schaeffer EM; Stief C; Zorn KC
Eur Urol; 2012 Apr; 61(4):664-75. PubMed ID: 22169079
[TBL] [Abstract][Full Text] [Related]
11. Trifecta outcomes after robotic-assisted laparoscopic prostatectomy.
Shikanov SA; Zorn KC; Zagaja GP; Shalhav AL
Urology; 2009 Sep; 74(3):619-23. PubMed ID: 19592075
[TBL] [Abstract][Full Text] [Related]
12. Impact of pelvic biometric measurements, visceral and subcutaneous adipose tissue areas on trifecta outcome and surgical margin status after open radical retropubic prostatectomy.
Ongun S; Demir O; Gezer NS; Gurboga O; Bozkurt O; Secil M
Scand J Urol; 2015 Apr; 49(2):108-14. PubMed ID: 25319551
[TBL] [Abstract][Full Text] [Related]
13. The trifecta outcome in 300 consecutive cases of robotic-assisted laparoscopic radical prostatectomy according to D'Amico risk criteria.
Ou YC; Yang CK; Wang J; Hung SW; Cheng CL; Tewari AK; Patel VR
Eur J Surg Oncol; 2013 Jan; 39(1):107-13. PubMed ID: 23085148
[TBL] [Abstract][Full Text] [Related]
14. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate.
Walsh PC
J Urol; 2000 Jun; 163(6):1802-7. PubMed ID: 10799186
[TBL] [Abstract][Full Text] [Related]
15. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer.
Sanderson KM; Penson DF; Cai J; Groshen S; Stein JP; Lieskovsky G; Skinner DG
J Urol; 2006 Nov; 176(5):2025-31; discussion 2031-2. PubMed ID: 17070244
[TBL] [Abstract][Full Text] [Related]
16. Achieving optimal outcomes after radical prostatectomy.
Saranchuk JW; Kattan MW; Elkin E; Touijer AK; Scardino PT; Eastham JA
J Clin Oncol; 2005 Jun; 23(18):4146-51. PubMed ID: 15961762
[TBL] [Abstract][Full Text] [Related]
17. Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer.
Loeb S; Smith ND; Roehl KA; Catalona WJ
Urology; 2007 Jun; 69(6):1170-5. PubMed ID: 17572209
[TBL] [Abstract][Full Text] [Related]
18. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy.
Glickman L; Godoy G; Lepor H
J Urol; 2009 Feb; 181(2):731-5. PubMed ID: 19091349
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of methods for reporting combined outcomes after radical prostatectomy and proposal of a novel system: the survival, continence, and potency (SCP) classification.
Ficarra V; Sooriakumaran P; Novara G; Schatloff O; Briganti A; Van der Poel H; Montorsi F; Patel V; Tewari A; Mottrie A
Eur Urol; 2012 Mar; 61(3):541-8. PubMed ID: 22153926
[TBL] [Abstract][Full Text] [Related]
20. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
Delongchamps NB; Zerbib M; Mejean A; Rouach Y; Debre B; Peyromaure M
Can J Urol; 2009 Oct; 16(5):4813-9. PubMed ID: 19796456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
